These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10701329)

  • 1. [Sudden death (V). Identification and treatment of patients with hypertrophic cardiomyopathy at risk of sudden death].
    McKenna WJ; Monserrat Iglesias L
    Rev Esp Cardiol; 2000 Jan; 53(1):123-30. PubMed ID: 10701329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk stratification of sudden death in hypertrophic cardiomyopathy in 2016].
    Dubourg O; Charron P; Sirol M; Siam-Tsieu V; Mansencal N
    Presse Med; 2016 Oct; 45(10):903-910. PubMed ID: 27234906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden death in hypertrophic cardiomyopathy: risk stratification and prevention.
    Valgaeren G; Conraads V; Colpaert C; Rademakers F; Vrints C
    Acta Cardiol; 1998; 53(1):23-9. PubMed ID: 9638966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
    Adamczak DM; Oko-Sarnowska Z
    Cardiol Rev; 2018; 26(3):145-151. PubMed ID: 29621050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.
    Kohorst JJ; Bos JM; Hagler DJ; Ackerman MJ
    Congenit Heart Dis; 2014; 9(2):E51-7. PubMed ID: 23648018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for hypertrophic cardiomyopathy in young athletes.
    Corrado D; Basso C; Schiavon M; Thiene G
    N Engl J Med; 1998 Aug; 339(6):364-9. PubMed ID: 9691102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for triggers of sudden death in hypertrophic cardiomyopathy: chasing after the wind?
    Jayachandran JV
    Heart Rhythm; 2009 May; 6(5):603-4. PubMed ID: 19389646
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.
    McKenna WJ; Behr ER
    Heart; 2002 Feb; 87(2):169-76. PubMed ID: 11796562
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott PM
    Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
    [No Abstract]   [Full Text] [Related]  

  • 13. Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Jahnlová D; Tomašov P; Zemánek D; Veselka J
    Int J Cardiol; 2015; 186():3-4. PubMed ID: 25804453
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
    Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
    Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
    [No Abstract]   [Full Text] [Related]  

  • 16. The prevention of sudden death in hypertrophic cardiomyopathy.
    Sachdev B; Hamid MS; Elliott PM
    Expert Opin Pharmacother; 2002 May; 3(5):499-504. PubMed ID: 11996628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple algorithm for a clinical step-by-step approach in the management of hypertrophic cardiomyopathy.
    Efthimiadis G; Zegkos T; Parcharidou D; Ntelios D; Panagiotidis T; Gossios T; Karvounis H
    Future Cardiol; 2021 Nov; 17(8):1395-1405. PubMed ID: 33615852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertrophic cardiomyopathy and sudden cardiac death--ICD indications in the margin of uncertainty].
    Fauchère I; Duru F
    Praxis (Bern 1994); 2009 Aug; 98(17):941-52. PubMed ID: 19711287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy: A complex disease.
    Young L; Smedira NG; Tower-Rader A; Lever H; Desai MY
    Cleve Clin J Med; 2018 May; 85(5):399-411. PubMed ID: 29733784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.